Is NCT07402382 recruiting in Canfield, OH?

Yes, NCT07402382 is currently recruiting participants at its Canfield, OH location. This glucose monitoring, continuous clinical trial is actively enrolling qualified participants.

How do I join the glucose monitoring, continuous clinical trial in Canfield?

To join this clinical trial in Canfield, complete the eligibility form on this page. A study coordinator will contact you to discuss next steps and determine if you qualify.

Is participation in this Canfield clinical trial free?

Yes, all study-related care is provided at no cost to qualified participants. Many studies also offer compensation for time and travel expenses.

Glucose Monitoring, Continuous Clinical Trial in Canfield, OH

About This Glucose Monitoring, Continuous Study in Canfield

The goal of this study is to better understand how an amylopectin chromium blend may influence whole body protein balance in women during midlife, when hormonal changes can adversely affect protein metabolism and muscle maintenance. Continuous glucose monitoring will also be used to assess glycemic control over a 24-hour period. The main questions the study aims to answer are: * Does the use of an amylopectin chromium blend in peri- and post-menopausal women help to support positive protein balance * Can the affect be achieved using a concentrated dose Researchers will compare the nutritional supplement to a placebo (amylopectin alone) to see if the amylopectin chromium blend can promote positive protein balance. A concentrated dose of the supplement will also be evaluated for comparative effectiveness. Participants will: * Consume the nutritional supplement (standard or concentrated dose) or placebo acutely after a short resistance exercise bout * Complete four in-person visits, including the single-day intervention Results from this research may help guide future nutritional strategies to support healthy aging, muscle function, and overall metabolic health.

Sponsor: Nutrition 21, Inc.

Who Can Participate

Inclusion Criteria

• Women aged 40-65 years who meet either of the following menstrual-history criteria:

≥ 60 days but \< 12 months of amenorrhea (late perimenopause)

Women with ≥ 12 months of spontaneous amenorrhea (post-menopausal)

No more than 3 days per week of structured physical activity

Provide voluntary signed and dated informed consent.

Be in good health and able to participate in an exercise bout as determined by assessment, medical history, and routine blood chemistries.

Between the of 40 and 65 years of age (inclusive).

Body Mass Index of 18.5-34.9 (inclusive).

Body weight of at least 110 pounds.

Normotensive (seated, resting systolic blood pressure \<140 mm Hg and diastolic blood pressure \< 90 mm Hg. If the first measurement is slightly elevated above these limits, the subject will be given a brief (5-minute) rest period, and two more measurements will be taken. The average of all three measurements will be used to determine eligibility.

Normal supine, resting heart rate (\<90 per minute).

Subject agrees to follow standardized controlled diet for 3 days and maintain existing dietary patterns on other days throughout the study period.

Subject is willing and able to comply with the study protocol.

Able to provide an adequate blood draw.

If a dietary supplement was initiated within the past month, the participant is willing to discontinue supplement use followed by a 2-week washout prior to participation in the study. Note: A generic multivitamin is allowed.

Refrain from caffeine, exercise, and alcohol for 24 hours prior, and fast for 10 hours prior to each visit.

Exclusion Criteria

Current use of any dietary ingredient that impacts glucose control or insulin sensitivity.

Current vegans or vegetarians.

Intolerance to dairy foods/drinks.

Smokes more than 10 cigarettes per day or uses other nicotine products (i.e. vape, patch) that deliver a similar amount of nicotine.

History of malignancy in the previous 5 years except for non-melanoma skin cancer (basal cell cancer or squamous cell cancer of the skin).

Prior gastrointestinal bypass surgery (Lapband, etc.).

Individuals using any kind of GLP-1 medications.

Other known gastrointestinal or metabolic diseases that might impact nutrient absorption or metabolism, e.g. electrolyte abnormalities, diabetes, thyroid disease, adrenal disease, hypogonadism, short bowel syndrome, diarrheal illnesses, history of colon resection, gastric ulcer, reflux disease, gastroparesis, Inborn-Errors-of-Metabolism (such as PKU).

Individuals who have gained or lost more than 10 pounds within the last 30 days.

Individuals who are cognitively impaired and/or who are unable to give informed consent.

Chronic medically diagnosed inflammatory condition or disease (e.g. rheumatoid arthritis, Crohn's disease, ulcerative colitis, Lupus, HIV/AIDS, etc.).

Medical history of hepatorenal, musculoskeletal, autoimmune, or neurologic disease.

Known sensitivity to any ingredient in the test formulations as listed in the Certificates-of-Analysis.

Any other diseases or conditions that, in the opinion of the medical staff, could confound the primary endpoint or place the subject at increased risk of harm if they were to participate.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Canfield?

Yes, this clinical trial (NCT07402382) has an active research site in Canfield, OH that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Glucose Monitoring, Continuous Treatment Options in Canfield, OH

If you're searching for glucose monitoring, continuous treatment options in Canfield, OH, this clinical trial (NCT07402382) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Canfield research site is actively enrolling participants for this clinical trial. You'll receive care from experienced glucose monitoring, continuous specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all glucose monitoring, continuous clinical trials near you to find additional studies recruiting in your area.

Glucose Monitoring, Continuous Clinical Trial in Canfield, OH

Expert Care in Canfield

IRB Approved

No-Cost Care

Apply for This Canfield Location

Why Participate?

Simple Process